Hypothalamus/Pituitary Flashcards

1
Q

Pituitary development and anatomy

A

anterior (adenohypophysis): derived from ectoderm

posterior (neurohypophysis): derived from floor of diencephalon (hypothalamus); maintains connection to hypothalamus via pituitary stalk

located in bony sella turcica (laterally bounded by cavernous sinus, anterioinferiorly bounded by sphenoid sinus, superiorly lies optic chiasm)

vessels (hypophyseal portal system) delivers hypothalamic releasing hormones to the anterior pituitary

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pituitary Corticotropin (ACTH)

A
  • Regulated by Corticotropin-Releasing Hormone (CRH) from hypothalamus
  • The target organ is the adrenal glands, stimulating cortisol synthesis and secretion
  • Cortisol has a negative feedback on ACTH secretion (and some on CRH)
  • Excess leads to Cushing’s syndrome
  • Deficiency leads to secondary adrenal insufficiency
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pituitary Thyroid Stimulating Hormone (TSH)

A
  • Regulated by Thyrotropin-Releasing Hormone (TRH)
  • The target organ is the thyroid gland, stimulating thyroid hormone synthesis and secretion
  • Thyroid hormones have a negative feedback on TSH secretion
  • Excess leads to central hyperthyroidism
  • Deficiency leads to central hypothyroidism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Pituitary Growth Hormone (GH)

A
  • Regulated by Growth Hormone-Releasing Hormone (GHRH) and Somatostatin (-) from hypothalamus
  • The target organs are multiple tissues (bone, cartilage, muscles…..), mainly through the action of IGF1(synthesized in the liver)
  • IGF1 has a negative feedback on GH
  • Excess leads to gigantism or acromegaly
  • Deficiency leads to growth retardation or an adult clinical syndrome
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pituitary Gonadotropins (LH/FSH)

A
  • LH (Luteinizing Hormone) and FSH (Follicle Stimulating Hormone)
  • Regulated by Gonadotropin-Releasing Hormone (GnRH) from hypothalamus
  • The target organs are the testes and ovaries, leading to testosterone secretion and spermatogenesis in males, as well as estradiol secretion and gametogenesis in females
  • Excess leads to precocious puberty
  • Deficiency leads to hypogonadism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Pituitary Prolactin (PRL)

A
  • Regulated by dopamine (tonic inhibition)
  • The target organ is the breast (mammary glands), leading to initiation and maintenance of lactation
  • Excess leads to galactorrhea and amenorrhea
  • Deficiency leads to the inability to lactate after delivery

**only hormone under tonic inhibition!

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Posterior Pituitary ADH (vasopressin)

A
  • Regulated mainly by plasma osmolality and “effective” circulating blood volume
  • The target organ is the collecting tubule, leading to increase in water permeability
  • Excess leads to SIADH (Syndrome of Inappropriate Secretion of Antidiuretic Hormone)
  • Deficiency leads to central diabetes insipidus
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Posterior Pituitary Oxytocin

A
  • Regulated by neurotransmitters (cholinergic, a-adrenergic)
  • The target organs are:
  • Breasts
  • uterus

Role:

  • Milk let-down reflex
  • Uterine contractions during labor
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Causes of cushings syndrome:

-ACTH-dependent

ACTH-independent

Pseudo-cushings

A

ACTH-dependent:

  • cushing’s disease
  • ectopic ACTH
  • Ectopic CRH

ACTH-independent:

  • adrenal adenoma
  • adrenal carcinoma
  • micronodular hyperplasia
  • macronodular hyperplasia

Pseudo-cushings

  • Major depressive d/o
  • alcoholism
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

signs and symptoms of cushing’s disease

A
  • centripetal obesity
  • Moon facies
  • buffalo hump
  • hirsutism
  • hyperpigmentation due to ACTH excess
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Sx: centripetal obesity, glucose intolerance, proximal muscle weakness, HTN, hirsutism, hyperpigmentation, tinea versicolor infection

Tests?

  • Positive Urine free cortisol

Identfiying Etiology?

  • plasma ACTH=30
  • Cortisol suppressed with high dose dexamethasone test

Dx?

Tx?

A

Tests:

  1. 24h Urine free cortisol collection: diagnostic if >3x normal, best screening test
  2. overnight low dose dexamethasone suppression test: postiive if pt does not suppress 8am cortisol to <1.8ng/dl
  3. salivary cortisol at midnight: positive if cortisol elevated

Etiology: determine ACTH dependency

-plasma ACTH

  • <5pg/ml–> adrenal cushings–>CT scan adrenals
  • >20pg/ml–>pituitary or ectopic cushings
  • between 5-20: not definitive

-pituitary vs ectopic cushings:

  • high dose dexamethasone suppression test: pts with pituitary cushings will be able to suppress ACTH secretion but ectopic will not
  • petrosal sinus sampling: pituitary cushings will have high ACTH

Dx: Pituitary Cushings’ disease

Tx: surgical resection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q
Sx:  Acral enlargement / Facial changes / Heel pad thickness \> 22 mm, Prognathism / Malocclusion, Arthralgias / Carpal tunnel syndrome, Excessive sweating
 Skin tags / Greasy, oily skin, Hypertension and Diabetes
 Sleep apnea (obstructive)

Tests?

  • positive IGF-1
  • Positive OGTT

Dx?

Tx?

A

Tests:

  • IGF-1 (Somatomedin C) : high; Best screening test
  • Failure of GH to suppress after OGTT (Oral Glucose Tolerance Test): Gold standard test (In acromegalics, GH does not suppress to < 1 ng/ml)
  • If testing positive => MRI of pituitary (usually macroadenoma)

Dx: Acromegaly due to excess GH

Tx:

  • transphenoidal surgery (curative 50%)
  • if not cured by sugery use: somatostatin analog (octreotide), radiation, GH receptor antagonists
  • screen for colon polyps/cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

long term consequences of acromegaly

A
  • arthropathy
  • neuropathy
  • CV disease–cardiomyopathy
  • hypertension
  • respiratory disease–airway obstruction
  • malignancy–colon polyps
  • Carbohydrate intolerance–Diabetes, IGT
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Female Sx: amenorrhea, infertility, galactorrhea

Male Sx: decreased libido, impotence, headache/vision changes (mass effect)

Tests: abnormal pituitary MRI w/?

Dx?

Tx?

A

Tests: high prolactin with abnormal pituitary on MRI

Need to exclude other etiologies:

  • Nonfunctioning pituitary macroadenoma with compression of the stalk (will show on MRI)
  • Infiltrative diseases of the hypoth/pituitary axis (sarcoid, histiocytosis X etc)
  • Primary hypothyroidism (high prolactin)
  • Renal failure, Cirrhosis (can’t excrete prolactin)
  • Pregnancy, Stress (ammenorhic women, send for pregnancy test)
  • Drugs: Dopamine antagonists (mainly antipsychotics)

Dx: prolactinoma

Tx: almost always medical!

  • Dopamine agonists: bromocriptine (Parlodel) or cabergoline (Dostinex)
  • surgery reserved for pts not responding to drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Thyrotrope adenoma

clinical presentation?

treatment?

A

-Secreting TSH
-Rare: less than 1% of all pituitary tumors
2 clinical presentations:

  • Hyperthyroidism with classic symptoms, goiter, high T4/T3 but inappropriately normal or elevated TSH (Remember: in primary hyperthyroidism, TSH is suppressed)
  • Mass effects: headache, abnormal visual fields

Treatment: Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

GONADOTROPE ADENOMA

clinical presentation

treatment

A
  • Secreting FSH (most common), LH or  subunit
  • Frequently referred to as “nonfunctioning” adenomas
  • No obvious clinical endocrine syndrome from this hypersecretion

-2 clinical presentations:

  • Mass effects: headache, abnormal visual fields
  • Hypopituitarism (deficiency of other hormones from macroadenoma)

Treatment: Surgery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Sx: polyuria/polydipsia, likes iced drinks

Tests: polyura+ urine specific gravity 1.005 or less + urine osmolality of 200mmol/l or less

Determining Etiology?

A

Dx: diabetes insipidus due to insufficient secretion of ADH (central) or resistance of kidney to ADH (nephrogenic)

Etiology: Central DI responds to ddAVP and nephrogenic does not

Tx:

  • central DI: ddAVP
  • nephrogenic DI: NSAIDS
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Causes of central DI

A
  • Congenital (autosomal dominant)
  • Acquired:
  • Iatrogenic (following neurosurgery)
  • Trauma
  • Neoplasms (pituitary tumors, craniopharyngioma….)
  • Ischemia (Sheehan’s syndrome)
  • Granulomas (Sarcoidosis….)
  • Infections (Tuberculosis…)
  • Autoimmune
  • Idiopathic
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

CAUSES of NEPHROGENIC DI

A
  • Congenital (X-linked)
  • Acquired:
  • Renal disease: sickle cell disease, polycystic kidney disease, amyloidosis, obstructive uropathy…
  • Electrolyte disorders: hypokalemia, hypercalcemia (at level of kidney)
  • Drugs: lithium, demeclocycline…
22
Q

hypopituitarism

A
  • Clinical syndrome resulting from the deficiency of one or multiple pituitary hormones (partial/panhypopituitarism)
  • GH, FSH and LH are often lost first; TSH, ACTH and ADH are usually last to be diminished, in that order
  • The most common cause is a pituitary macroadenoma
23
Q

Sheehan’s syndrome

A
  • Results from ischemic pituitary necrosis following childbirth
  • It is almost always associated with severe postpartum hemorrhage and hypotension
  • The tip-off to its occurrence is failure to lactate postpartum
24
Q

Pituitary apoplexy

def?

presentation?

work-up?

treatment>

A
  • Results from hemorrhagic infarction of a pituitary adenoma
  • Acute presentation with headaches, change in mental status, ophthalmoplegia and visual loss, sometimes necessitating surgical decompression (if severe)
  • Variable degrees of hypopituitarism

Workup should include:

  • MRI of the hypothalamus/pituitary
  • Endocrine testing: PRL, TSH & free T4, cortisol & ACTH (and if necessary, dynamic testing), testosterone in males, menstrual history in females, GH dynamic testing

Treatment depends on the etiology

  • May include neurosurgical intervention
  • Hormonal replacement
25
26
pituitary incidentalomas
- 10-20% of people (most common is pituitary microadenoma) - Need to exclude hormonal hypersecretion: PRL, IGF-1, TSH & free T4, overnight dexamethasone suppression test, LH, FSH & a-subunit - If macroadenoma =\> also need to rule out hypopituitarism (see appropriate section) and do formal visual fields testing - If all testing is normal, follow with periodic MRI (6 months, 1, 2 and 5 years)
27
High uptake hyperthyroidism
* Grave's disease * toxic multi-nodular goiter * toxic adenoma * TSH induced hyperthyroidism * trophoblastic disease (choriocarcinoma, hyadatiform mole secrete hCG which stimulates thyroid)
28
low uptake hyperthyroidism
* painful thyroiditis (subuacute, DeQuervain's) * painless thyroiditis (post-partum) * iodine induced hyperthyroidism * exogenous T3/T4 ingestion * struma ovarii * metastatic follicular carcinoma
29
thyroid storm
severe hyperthyroidism, fever, change in mental status
30
**Sx:** • Diffuse goiter w/ bruits • Opthalmopathy: o Non-infiltrative: grittiness, redness, lacrimation, lid lag, lid retraction) o Proptosis \*pathognomonic Grave’s (infiltrative) o Interferene w/ venous drainage o Extra-ocular muscle palsy (ocular nerve entrapment→blindness) • Dermopathy: o Onycholysis: retraction of nail from bed o Acropachy (clubbing)\*pathognomic Graves o Pretibial myxedema **Lab Tests:** • Elevated TSH and T3/4 • Radioisotope study: o High uptake hyperthyroidism Dx?
Dx: hyperthyroidism Grave's disease due to auto-antibodies stimulating TSH receptor
31
myxedema coma
hypothermia, hypoventilation, hyponatremia, depressed mental status
32
risk of malignancy in thyroid nodules...
- 5% to 10% incidence of overt cancer - Age: \< 20 yrs. \> 60 yrs. (10-20% ) - Sex: ♂:♀ 3:1 (nodules ♀: ♂ 4:1) - H&N XRT: Childhood XRT: 33%  in malignancy (3 yr -- peak 20 yrs) - Family history: MEN II
33
histology of thyroid nodule
- 70% are colloid nodules, 20% adenomas, 10% carcinomas (30% are tumors but only 10% malignant) - clinical hallmarks of malignancy: * rapid growth, * firm, fixed nodules on PE * local lymphadenopathy * distant metastases * vocal cord paralysis
34
Evaluating thyroid nodules
1) ultrasound: * distiguish solid vs cystic * size 2) radionuclear screening: * most nodules appear "cold" on scan; 5-10% of these are malignant * autonomously functioning nodules (independent of TSH) are hot and rarely malignant 3) FNAB: procedure of choice, perform on all nodules * benign: 70% * malignant: 5% * suspicious: 15% * insufficient: 10% Malignant and suspicious nodules should go to surgery.
35
evaluation of thyroid incidentalomas
• Depends on size of nodule: * \<1cm and low risk of cancer: repeat follow-up ultrasound, if enlarges FNAB (or if have initially high risk cancer) * \>1cm: requires FNAB
36
papillary thyroid carcinoma
70-80% of all thyroid carcinomas women , peak age in 30s mets to regional lymph nodes excellent prognosis
37
follicular thyroid carcinoma
20% thyroid cancer median age 50 years hematogenous spread (to lung/bone) worse prognosis than papillary
38
medullary thyroid carcinoma
assoc. with MEN2 syndromes 90% are sporadic tumor markers: calcitonin and CEA cannot be treated with I131
39
anaplastic thyroid carcinoma
rare tumor, mean age 70 aggressive, rapidly fatal
40
lymphoma thyroid cancer
rare assoc. w/ hashimotos thyroiditis
41
States leading to high Thyroid binding globulin
estrogens (OCP, pregnancy), acute or chronic hepatitis, acute intermittent porphyria, hereditary
42
states leading to low TBG
adrogens, glucocorticoids, nephrotic syndrome, hereditary
43
MEN-1
1. Pituitary adenoma 2. parathyroid hyerplasia 3. pancreatic tumors
44
MEN-2A
1. parathyroid hyperplasia 2. medullary thyroid carcinoma 3. pheochromocytoma
45
MEN-2B
1. mucosal neuromas 2. marfanoid body 3. medullary thyroid carcinoma 4. pheochromocytoma
46
žPrimary Hyperparathyroidism (PHPT) lab findings
Lab Findings: •↑ Serum Ca , ↑ PTH , ↑ Urinary Calcium
47
•Familial Hypocalciuric Hypercalcemia (FHH) Lab Findings:
Lab Findings: –↑ Serum Ca , ↑ PTH (not as elevated as PHPT) , ↓ Urine Calcium No surgery!